High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania

Tropical Medicine and International Health

Volumn 16, Issue 10, 2011, Pages 1291-1296

  Mullin, Stephen ^a   Temu, A ^b   Kalluvya, S ^b   Grant, A ^c   Manji, H ^d  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST   (United Kingdom)

^b CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Africa; Didanosine; HIV; Neuropathy; Stavudine; Tanzania

Indexed keywords

ABACAVIR; CD4 ANTIGEN; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR; NELFINAVIR PLUS RITONAVIR; NEVIRAPINE; RITONAVIR PLUS SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

CONFIDENCE INTERVAL; DISEASE PREVALENCE; DISEASE TREATMENT; DRUG; HEALTH IMPACT; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; NERVOUS SYSTEM DISORDER; PUBLIC HEALTH; SENSORY SYSTEM DISORDER; SYMPTOM;

ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PREVALENCE; SENSORY NEUROPATHY; SEX DIFFERENCE; TANZANIA; TREATMENT DURATION; TREATMENT OUTCOME; VIROTHERAPY;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DIDANOSINE; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; HYPESTHESIA; MALE; MIDDLE AGED; PAIN; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHIES; PREVALENCE; STAVUDINE; TANZANIA;

TANZANIA;

EID: 80052901590     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2011.02825.x     Document Type: Article

References (18)

1. Cherry CL, Wesselingh SL, Lal L & McArthur JC (2005) Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology 65, 1778-1781.
2. Cherry CL, Affandi JS, Imran D et al. (2009) Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology 73, 315-320.
3. Childs EA, Lyles RH, Selnes OA et al. (1999) Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52, 607-613.
4. Forna F, Liechty CA, Solberg P et al. (2007) Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. Journal of acquired immune deficiency syndromes (1999) 44, 456-462.
5. Maritz J, Benatar M, Dave JA et al. (2010) HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle and Nerve 41, 599-606.
6. Maschke M, Kastrup O, Esser S et al. (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). Journal of neurology, neurosurgery, and psychiatry 69, 376-380.
7. McArthur JH (1998) The reliability and validity of the subjective peripheral neuropathy screen. The Journal of the Association of Nurses in AIDS Care JANAC 9, 84-94.
8. McArthur JC, Brew BJ & Nath A (2005) Neurological complications of HIV infection. Lancet neurology, 4, 543-555.
9. Mehta SA, Ahmed A, Kariuki BW et al. (2010) Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya. The American Journal of Tropical Medicine and Hygiene 83, 565-570.
10. van Oosterhout JJ, Bodasing N, Kumwenda JJ et al. (2005) Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Tropical medicine & international health TM & IH, 10, 464-470.
11. Parry O, Mielke J, Latif AS et al. (1997) Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurologica Scandinavica 96, 218-222.
12. Robinson-Papp J & Simpson DM (2009) Neuromuscular diseases associated with HIV-1 infection. Muscle and Nerve 40, 1043-1053.
13. Shurie JS & Deribew A (2010) Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals. Ethiopian medical journal 48, 85-93.
14. Simpson DM, Kitch D, Evans SR et al. (2006) HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 66, 1679-1687.
15. Tagliati M, Grinnell J, Godbold J & Simpson DM (1999) Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Archives of Neurology 56, 84-89.
16. Wadley AL, Cherry CL, Price P et al. (2010) HIV Neuropathy Risk Factors and Symptom Characterization in Stavudine-Exposed South Africans. Journal of pain and symptom management 41, 700-706.
17. Wester CW, Kim S, Bussmann H et al. (2005) Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. Journal of acquired immune deficiency syndromes 40, 336-343.
18. WHO. (2010) Antiretroviral therapy for HIV infection in adults and adolescents. Available from:.